Wipro GE Healthcare Names VS Raghavendra Rao New MD

Wipro GE Healthcare has appointed VS Raghavendra Rao, who joined the company in 2002, as Managing Director and President & CEO of GE HealthCare South Asia, effective January 4, 2027. He succeeds Chaitanya Sarawate, who is leaving to pursue external opportunities after 16 years with GE HealthCare.

Stockfame Editorial
Published: (25 min ago)
Last updated:
5 min read
WhatsApp

Key takeaways

  • VS Raghavendra Rao will become Managing Director of Wipro GE Healthcare and President & CEO, GE HealthCare South Asia, effective January 4, 2027.
  • He succeeds Chaitanya Sarawate, who is leaving GE HealthCare after 16 years to pursue external opportunities.
  • Rao has been with the organisation since 2002 and will report to Rishad Premji and Catherine Estrampes.
  • The company has flagged deeper localisation, faster innovation and wider access to quality care as priorities.

Wipro GE Healthcare has named a long-serving insider to lead its India and South Asia business. The medical technology, diagnostics and digital solutions company announced that VS Raghavendra Rao will take over as Managing Director of Wipro GE Healthcare and President & CEO of GE HealthCare South Asia, effective January 4, 2027. He joined the organisation in 2002 and succeeds Chaitanya Sarawate, who is moving on to pursue external opportunities.

What happened

The announcement was made from Bengaluru through a Business Wire India release. Under the new arrangement, Rao will carry two linked responsibilities: running Wipro GE Healthcare, the India-based entity, and leading GE HealthCare's wider South Asia operations as President & CEO.

In his new role, Rao will report to two senior leaders:

  • Rishad Premji, Chairman, Wipro GE Healthcare Private Ltd.
  • Catherine Estrampes, Chief Commercial and Growth Officer, GE HealthCare.

According to the company, Rao will advance the growth agenda for India and South Asia. The stated focus areas are deepening localisation, accelerating innovation and expanding access to quality care.

Who is VS Raghavendra Rao

Rao has spent more than two decades at Wipro GE Healthcare. He joined in 2002 and has held a range of leadership positions across the business since then. The company describes him as having a proven record of building and scaling businesses in a complex and changing healthcare market, backed by commercial and operational leadership experience.

The company said his elevation reflects the depth of leadership within the organisation and offers continuity as it pursues its ambitions in India and South Asia. Appointing an internal candidate is often read as a signal of strategic stability, since the incoming executive is already familiar with customers, products and internal processes. That is a general observation about succession practices and not a statement from the company.

Chaitanya Sarawate's exit

Sarawate is leaving GE HealthCare after 16 years of service across regional and global leadership roles. The company credited him with strengthening Wipro GE Healthcare's market leadership during his time heading India and South Asia, while advancing localisation, innovation and access. It also said he championed India's growing role within GE HealthCare's global innovation, engineering and manufacturing ecosystem, supporting the ambition to develop solutions "in India, for India and the world".

The release did not say where Sarawate will go next. It described his departure only as a move to pursue external opportunities.

What the leadership said

Catherine Estrampes said India and South Asia are strategically important to GE HealthCare, both as growth markets and as sources of innovation and manufacturing capability for the world. She said Rao brings a rare combination of market understanding, trusted customer relationships and the ability to turn strategy into sustained business impact. She added that she was confident he would build on the foundation Sarawate helped shape and carry the growth and access ambitions forward.

Rishad Premji said Wipro GE Healthcare has built a strong and enduring presence in India, grounded in a commitment to advancing care in the country. He said Rao's understanding of the business, customers and market positions him strongly to build on that base, and expressed confidence that the company would continue to deliver through deeper localisation, meaningful innovation and greater access to quality care. Both leaders thanked Sarawate for his contribution and wished him well.

Why it matters for investors

Wipro GE Healthcare Private Ltd. is a private company, so there is no stock directly tied to this appointment, and the release carried no financial figures, guidance or targets. For retail investors, the news is mainly a data point on how a prominent healthcare-technology player in India is managing leadership transition.

Senior management changes can matter for investors who follow the healthcare equipment and diagnostics space, because the leader of a business shapes priorities on pricing, product launches, service networks and manufacturing. However, the company has framed this as a continuity appointment, and no change in strategy has been announced. Investors should avoid reading more into the move than the release supports.

Background: India's role in the GE HealthCare story

The release underlines that India is gaining strategic importance for GE HealthCare, as a key healthcare market and as part of its global innovation and manufacturing network. The three themes repeated in the announcement are worth understanding in plain terms:

  • Localisation: designing, engineering or manufacturing products in the country rather than relying wholly on imports. This can help tailor equipment to local clinical needs and conditions, and may affect cost structures.
  • Innovation: developing new medical technologies, diagnostics and digital tools, including solutions meant for use beyond India.
  • Access: making quality diagnostic and care technologies available to more patients and a wider range of healthcare facilities.

Medical imaging and diagnostics are capital-intensive segments, where hospitals and diagnostic chains make long-term equipment decisions. Relationships with customers therefore carry weight, which is one reason the company highlighted Rao's trusted customer relationships.

What to watch next

  • Transition period: Rao's appointment takes effect on January 4, 2027. Any further announcements on the handover or on other organisational changes would be worth tracking.
  • Strategic priorities: Whether the company shares specifics on localisation, new product development or manufacturing plans in India once Rao assumes charge.
  • Sarawate's next role: The release says only that he is pursuing external opportunities.
  • Company disclosures: As a private company, Wipro GE Healthcare does not issue quarterly results in the way listed companies do, so updates are likely to arrive through press releases and corporate communications.

This article is based on a press release issued through Business Wire India. It is for information only and does not constitute investment advice.

Frequently asked questions

Who is the new Managing Director of Wipro GE Healthcare?

VS Raghavendra Rao has been appointed Managing Director of Wipro GE Healthcare and President & CEO, GE HealthCare South Asia, effective January 4, 2027.

Who is Raghavendra Rao replacing?

He succeeds Chaitanya Sarawate, who is leaving GE HealthCare after 16 years to pursue external opportunities.

How long has Raghavendra Rao been with Wipro GE Healthcare?

He joined the organisation in 2002 and has held a range of leadership roles since then, giving him more than two decades of experience there.

Whom will Raghavendra Rao report to?

He will report to Rishad Premji, Chairman of Wipro GE Healthcare Private Ltd., and Catherine Estrampes, Chief Commercial and Growth Officer at GE HealthCare.

Is Wipro GE Healthcare a listed company?

The release refers to it as Wipro GE Healthcare Private Ltd., which indicates a private company, so it has no stock of its own for investors to trade.

Make Stockfame a preferred source on GoogleSee our market stories first in Google Top Stories.
Get Stockfame stories first on GoogleFree · Done in 5 seconds · Undo anytime
KA
Reviewed byKritesh Abhishek

Kritesh Abhishek is an editor and reviewer at Stockfame with over 10 years of experience in financial news. An active investor for more than 13 years and the author of books on candlestick and chart-based trading, he reviews Stockfame's market and stock coverage, with a focus on what price moves, promoter actions and company news mean for retail investors.

Own a stock in this story? Check it for red flags in seconds. Open the checker →

This article is for information only and is not investment advice.